Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-007434

CVP, Critical Care sold 5,000 shares at $90.52 ($452,600)

  • CVP, Critical Care acquired 5,000 shares (option exercise)
  • CVP, Critical Care gave up 252 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Szyman Catherine M. · CVP, Critical Care

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-07 Shares withheld for taxes : show line 1 in the form 10b5-1 −252 $90.46 $22,796 34,813.57 D
2023-07-10 Exercise or conversion : show line 2 in the form 10b5-1 +5,000 $36.75 $183,750 39,813.57 D
2023-07-10 Sale : show line 3 in the form 10b5-1 −5,000 $90.52 $452,600 34,813.57 D
Open-market sales · 5,000 sh · avg $90.52 · $452,600

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-07-10 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −5,000 $36.75 2024-05-10 5,000 62,000 D
Loading xslF345X04/doc4.xml…